A structured nutrition, exercise, and mobile-health program alongside treatment was linked to weight loss with limited skeletal muscle loss and improved cardiometabolic markers.
Evidence
This retrospective chart review analyzed 171 adherent patients in one wellness program over 12 months, measuring body composition, glycemia, blood pressure, and lipid outcomes.
Caveat
The review was nonrandomized, limited to adherent program participants, and lacked a comparison group receiving GLP-1 RAs without the TouchCare Method.
Simplified
BACKGROUND: GLP-1 RAs are effective in treating obesity; however, they typically result in significant loss of . Real-world evidence to inform systematic guidelines and clinical implementation for preserving skeletal muscle mass and reducing cardiometabolic risk with lifestyle modifications on GLP-1 RAs remains limited.
OBJECTIVE: This study evaluated the effectiveness of the TouchCare Method, a lifestyle intervention incorporating nutrition and exercise with GLP-1 RAs, for improving body composition and cardiometabolic risk.
METHODS: A retrospective chart review included patients enrolled in Bucks Health and Wellness between February 2024 and September 2025, for at least 12 month ( = 187). The TouchCare Method incorporates registered dietitian counseling, progressive exercise programming, mobile self monitoring, and body composition analysis during visits. Primary outcomes included: clinically significant weight loss (> 10% of body weight), proportion of weight loss from skeletal muscle mass, and changes in total-C, LDL-C, Apolipoprotein B, Triglycerides, HbA1c, and blood pressure at 12 months. n
RESULTS: Patients adherent to the TouchCare Method for 12 months were included in the final analysis ( = 171). Clinically significant weight loss (≥ 10%) was achieved by 69.56% ( = 139) of patients. Skeletal muscle mass accounted for 12.22% ± 8.73% of total weight loss. Among prediabetic patients ( = 95), 74.7% ( = 71) reached euglycemia by 12 months. Patients with Stage II hypertension or higher (77% of the cohort) demonstrated improved blood pressure control, with most reaching < 140/90 mmHg. Patients with HLD experienced significant reductions in Total-C (24.71 ± 23.31 mg/dL), LDL-C (-13.75 ± 21.51 mg/dL), and ApoB (-14.24 ± 16.19 mg/dL). All lipid and HgA1c changes were statistically significant ( < 0.001). n n n n p
CONCLUSION: The TouchCare Method may improve treatment outcomes by providing comprehensive structured lifestyle interventions supporting clinically significant weight loss while preserving skeletal muscle mass and improving cardiometabolic risk factors.
Key numbers
69.56%
Weight Loss Achievement
Percentage of patients losing ≥ 10% of initial body weight at 12 months.
12.22%
Average Muscle Mass Loss
Percentage of total body weight loss attributed to at 12 months.
74.7%
Normalization of HbA1c
Percentage of prediabetic patients achieving HbA1c < 5.7% by 12 months.
Full Text
We can’t show the full text here under this license.
Dr. Elizabeth Sharp Edens is the founder of Bucks Health and Wellness and TouchCare Method, which are described in this study. The authors report no other conflicts of interest.
